Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Prevents Oxidative Stress in Uremic Rats
Chronic renal failure causes left ventricular hypertrophy, but the molecular mechanisms involved remain unknown. We, therefore, investigated whether the mineralocorticoid receptor is implicated in the cardiac hypertrophy observed in uremic rats and whether mineralocorticoid receptor blockade could b...
Gespeichert in:
Veröffentlicht in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2008-08, Vol.52 (2), p.295-300 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 300 |
---|---|
container_issue | 2 |
container_start_page | 295 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 52 |
creator | Michea, Luis Villagrán, Andrea Urzúa, Alvaro Kuntsmann, Sonia Venegas, Patricio Carrasco, Loreto Gonzalez, Magdalena Marusic, Elisa T |
description | Chronic renal failure causes left ventricular hypertrophy, but the molecular mechanisms involved remain unknown. We, therefore, investigated whether the mineralocorticoid receptor is implicated in the cardiac hypertrophy observed in uremic rats and whether mineralocorticoid receptor blockade could be protective in chronic renal failure. Experimental groups werecontrol rats, uremic rats (NPX) with 5/6 nephrectomy (5 weeks), and NPX rats fed with spironolactone for 5 weeks. Systolic blood pressure was increased in both NPX rats and NPX rats fed with spironolactone for 5 weeks. Echocardiography revealed concentric left ventricular hypertrophy in uremia, which was attenuated by spironolactone. Enlarged cardiomyocyte size was observed in both left and right ventricles of NPX rats, an effect that was prevented by spironolactone. Mineralocorticoid receptor antagonism attenuated the increase of ventricular brain natriuretic peptide mRNA levels induced by nephrectomy. Left ventricular gene expressions of aldosterone synthase, mineralocorticoid receptor, and hydroxysteroid dehydrogenase type 2 were the same in the 3 groups, whereas gene expression of the glucocorticoid receptor was significantly diminished in chronic renal failure rats. No significant differences in cardiac aldosterone were observed between control rats and NPX rats, although NPX rats fed with spironolactone for 5 weeks showed increased plasma aldosterone levels. However, a significant increase in serum and glucocorticoid-inducible kinase-1 mRNA expression and protein was present in the NPX group; spironolactone treatment significantly reduced serum and glucocorticoid-inducible kinase-1 mRNA and protein in the left ventricle. Uremic rats exhibited a significant increase of superoxide production and reduced nicotinamide-adenine dinucleotide phosphate oxidase subunits expression (NOX-2, NOX-4, and p47) in the left ventricle, which was prevented by the mineralocorticoid receptor antagonist. Our findings provide evidence of the beneficial effects of spironolactone in cardiac hypertrophy and cardiac oxidative stress in chronic renal failure. |
doi_str_mv | 10.1161/HYPERTENSIONAHA.107.109645 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69355037</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69355037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5214-bc97bbb23064f263c693940e25577ec9ce872b59b4e33d85ba8634cf40512a413</originalsourceid><addsrcrecordid>eNpdkF9rFDEUxYModq1-BQk--DY1f2cmvg3L1i3Ubtm2oE8hk7nrRmcm0yTTut_eyC4I3svlwuWcc-GH0AdKLigt6af199vV9n51c3e1uWnWzQUlVR5VCvkCLahkohCy5C_RglAlCkXptzP0JsafhFAhRPUandFaKipkvUCPX90IwfTe-pCc9a7DW7AwJR9wMybzw48uDrhJCcbZJIh4aULnjMXrwwQhBT_tD9iMHb4N8ARjinjz23UmuSfAdylAjNiN-CHA4CzemhTfolc700d4d9rn6OFydb9cF9ebL1fL5rqwklFRtFZVbdsyTkqxYyW3peJKEGBSVhVYZaGuWCtVK4DzrpatqUsu7E4QSZkRlJ-jj8fcKfjHGWLSg4sW-t6M4Oeoc56UhFdZ-PkotMHHGGCnp-AGEw6aEv0XuP4PeL5X-gg8m9-fvsztAN0_64lwFoij4Nn3CUL81c_PEPQeTJ_2muQSrKwLRkidm5AiDxP8D3taj6M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69355037</pqid></control><display><type>article</type><title>Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Prevents Oxidative Stress in Uremic Rats</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Ovid Autoload</source><creator>Michea, Luis ; Villagrán, Andrea ; Urzúa, Alvaro ; Kuntsmann, Sonia ; Venegas, Patricio ; Carrasco, Loreto ; Gonzalez, Magdalena ; Marusic, Elisa T</creator><creatorcontrib>Michea, Luis ; Villagrán, Andrea ; Urzúa, Alvaro ; Kuntsmann, Sonia ; Venegas, Patricio ; Carrasco, Loreto ; Gonzalez, Magdalena ; Marusic, Elisa T</creatorcontrib><description>Chronic renal failure causes left ventricular hypertrophy, but the molecular mechanisms involved remain unknown. We, therefore, investigated whether the mineralocorticoid receptor is implicated in the cardiac hypertrophy observed in uremic rats and whether mineralocorticoid receptor blockade could be protective in chronic renal failure. Experimental groups werecontrol rats, uremic rats (NPX) with 5/6 nephrectomy (5 weeks), and NPX rats fed with spironolactone for 5 weeks. Systolic blood pressure was increased in both NPX rats and NPX rats fed with spironolactone for 5 weeks. Echocardiography revealed concentric left ventricular hypertrophy in uremia, which was attenuated by spironolactone. Enlarged cardiomyocyte size was observed in both left and right ventricles of NPX rats, an effect that was prevented by spironolactone. Mineralocorticoid receptor antagonism attenuated the increase of ventricular brain natriuretic peptide mRNA levels induced by nephrectomy. Left ventricular gene expressions of aldosterone synthase, mineralocorticoid receptor, and hydroxysteroid dehydrogenase type 2 were the same in the 3 groups, whereas gene expression of the glucocorticoid receptor was significantly diminished in chronic renal failure rats. No significant differences in cardiac aldosterone were observed between control rats and NPX rats, although NPX rats fed with spironolactone for 5 weeks showed increased plasma aldosterone levels. However, a significant increase in serum and glucocorticoid-inducible kinase-1 mRNA expression and protein was present in the NPX group; spironolactone treatment significantly reduced serum and glucocorticoid-inducible kinase-1 mRNA and protein in the left ventricle. Uremic rats exhibited a significant increase of superoxide production and reduced nicotinamide-adenine dinucleotide phosphate oxidase subunits expression (NOX-2, NOX-4, and p47) in the left ventricle, which was prevented by the mineralocorticoid receptor antagonist. Our findings provide evidence of the beneficial effects of spironolactone in cardiac hypertrophy and cardiac oxidative stress in chronic renal failure.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.107.109645</identifier><identifier>PMID: 18591458</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Analysis of Variance ; Animals ; Biomarkers - analysis ; Blotting, Western ; Cardiomegaly - prevention & control ; Disease Models, Animal ; Immediate-Early Proteins - genetics ; Immediate-Early Proteins - metabolism ; Male ; Mineralocorticoid Receptor Antagonists - pharmacology ; Nephrectomy ; Oxidative Stress - drug effects ; Probability ; Protein-Serine-Threonine Kinases - genetics ; Protein-Serine-Threonine Kinases - metabolism ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptors, Mineralocorticoid - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - analysis ; Spironolactone - pharmacology ; Uremia - physiopathology ; Urinalysis</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2008-08, Vol.52 (2), p.295-300</ispartof><rights>2008 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5214-bc97bbb23064f263c693940e25577ec9ce872b59b4e33d85ba8634cf40512a413</citedby><cites>FETCH-LOGICAL-c5214-bc97bbb23064f263c693940e25577ec9ce872b59b4e33d85ba8634cf40512a413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,3689,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18591458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Michea, Luis</creatorcontrib><creatorcontrib>Villagrán, Andrea</creatorcontrib><creatorcontrib>Urzúa, Alvaro</creatorcontrib><creatorcontrib>Kuntsmann, Sonia</creatorcontrib><creatorcontrib>Venegas, Patricio</creatorcontrib><creatorcontrib>Carrasco, Loreto</creatorcontrib><creatorcontrib>Gonzalez, Magdalena</creatorcontrib><creatorcontrib>Marusic, Elisa T</creatorcontrib><title>Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Prevents Oxidative Stress in Uremic Rats</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Chronic renal failure causes left ventricular hypertrophy, but the molecular mechanisms involved remain unknown. We, therefore, investigated whether the mineralocorticoid receptor is implicated in the cardiac hypertrophy observed in uremic rats and whether mineralocorticoid receptor blockade could be protective in chronic renal failure. Experimental groups werecontrol rats, uremic rats (NPX) with 5/6 nephrectomy (5 weeks), and NPX rats fed with spironolactone for 5 weeks. Systolic blood pressure was increased in both NPX rats and NPX rats fed with spironolactone for 5 weeks. Echocardiography revealed concentric left ventricular hypertrophy in uremia, which was attenuated by spironolactone. Enlarged cardiomyocyte size was observed in both left and right ventricles of NPX rats, an effect that was prevented by spironolactone. Mineralocorticoid receptor antagonism attenuated the increase of ventricular brain natriuretic peptide mRNA levels induced by nephrectomy. Left ventricular gene expressions of aldosterone synthase, mineralocorticoid receptor, and hydroxysteroid dehydrogenase type 2 were the same in the 3 groups, whereas gene expression of the glucocorticoid receptor was significantly diminished in chronic renal failure rats. No significant differences in cardiac aldosterone were observed between control rats and NPX rats, although NPX rats fed with spironolactone for 5 weeks showed increased plasma aldosterone levels. However, a significant increase in serum and glucocorticoid-inducible kinase-1 mRNA expression and protein was present in the NPX group; spironolactone treatment significantly reduced serum and glucocorticoid-inducible kinase-1 mRNA and protein in the left ventricle. Uremic rats exhibited a significant increase of superoxide production and reduced nicotinamide-adenine dinucleotide phosphate oxidase subunits expression (NOX-2, NOX-4, and p47) in the left ventricle, which was prevented by the mineralocorticoid receptor antagonist. Our findings provide evidence of the beneficial effects of spironolactone in cardiac hypertrophy and cardiac oxidative stress in chronic renal failure.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Biomarkers - analysis</subject><subject>Blotting, Western</subject><subject>Cardiomegaly - prevention & control</subject><subject>Disease Models, Animal</subject><subject>Immediate-Early Proteins - genetics</subject><subject>Immediate-Early Proteins - metabolism</subject><subject>Male</subject><subject>Mineralocorticoid Receptor Antagonists - pharmacology</subject><subject>Nephrectomy</subject><subject>Oxidative Stress - drug effects</subject><subject>Probability</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Random Allocation</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Mineralocorticoid - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - analysis</subject><subject>Spironolactone - pharmacology</subject><subject>Uremia - physiopathology</subject><subject>Urinalysis</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkF9rFDEUxYModq1-BQk--DY1f2cmvg3L1i3Ubtm2oE8hk7nrRmcm0yTTut_eyC4I3svlwuWcc-GH0AdKLigt6af199vV9n51c3e1uWnWzQUlVR5VCvkCLahkohCy5C_RglAlCkXptzP0JsafhFAhRPUandFaKipkvUCPX90IwfTe-pCc9a7DW7AwJR9wMybzw48uDrhJCcbZJIh4aULnjMXrwwQhBT_tD9iMHb4N8ARjinjz23UmuSfAdylAjNiN-CHA4CzemhTfolc700d4d9rn6OFydb9cF9ebL1fL5rqwklFRtFZVbdsyTkqxYyW3peJKEGBSVhVYZaGuWCtVK4DzrpatqUsu7E4QSZkRlJ-jj8fcKfjHGWLSg4sW-t6M4Oeoc56UhFdZ-PkotMHHGGCnp-AGEw6aEv0XuP4PeL5X-gg8m9-fvsztAN0_64lwFoij4Nn3CUL81c_PEPQeTJ_2muQSrKwLRkidm5AiDxP8D3taj6M</recordid><startdate>200808</startdate><enddate>200808</enddate><creator>Michea, Luis</creator><creator>Villagrán, Andrea</creator><creator>Urzúa, Alvaro</creator><creator>Kuntsmann, Sonia</creator><creator>Venegas, Patricio</creator><creator>Carrasco, Loreto</creator><creator>Gonzalez, Magdalena</creator><creator>Marusic, Elisa T</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200808</creationdate><title>Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Prevents Oxidative Stress in Uremic Rats</title><author>Michea, Luis ; Villagrán, Andrea ; Urzúa, Alvaro ; Kuntsmann, Sonia ; Venegas, Patricio ; Carrasco, Loreto ; Gonzalez, Magdalena ; Marusic, Elisa T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5214-bc97bbb23064f263c693940e25577ec9ce872b59b4e33d85ba8634cf40512a413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Biomarkers - analysis</topic><topic>Blotting, Western</topic><topic>Cardiomegaly - prevention & control</topic><topic>Disease Models, Animal</topic><topic>Immediate-Early Proteins - genetics</topic><topic>Immediate-Early Proteins - metabolism</topic><topic>Male</topic><topic>Mineralocorticoid Receptor Antagonists - pharmacology</topic><topic>Nephrectomy</topic><topic>Oxidative Stress - drug effects</topic><topic>Probability</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Random Allocation</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Mineralocorticoid - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - analysis</topic><topic>Spironolactone - pharmacology</topic><topic>Uremia - physiopathology</topic><topic>Urinalysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Michea, Luis</creatorcontrib><creatorcontrib>Villagrán, Andrea</creatorcontrib><creatorcontrib>Urzúa, Alvaro</creatorcontrib><creatorcontrib>Kuntsmann, Sonia</creatorcontrib><creatorcontrib>Venegas, Patricio</creatorcontrib><creatorcontrib>Carrasco, Loreto</creatorcontrib><creatorcontrib>Gonzalez, Magdalena</creatorcontrib><creatorcontrib>Marusic, Elisa T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Michea, Luis</au><au>Villagrán, Andrea</au><au>Urzúa, Alvaro</au><au>Kuntsmann, Sonia</au><au>Venegas, Patricio</au><au>Carrasco, Loreto</au><au>Gonzalez, Magdalena</au><au>Marusic, Elisa T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Prevents Oxidative Stress in Uremic Rats</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2008-08</date><risdate>2008</risdate><volume>52</volume><issue>2</issue><spage>295</spage><epage>300</epage><pages>295-300</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><abstract>Chronic renal failure causes left ventricular hypertrophy, but the molecular mechanisms involved remain unknown. We, therefore, investigated whether the mineralocorticoid receptor is implicated in the cardiac hypertrophy observed in uremic rats and whether mineralocorticoid receptor blockade could be protective in chronic renal failure. Experimental groups werecontrol rats, uremic rats (NPX) with 5/6 nephrectomy (5 weeks), and NPX rats fed with spironolactone for 5 weeks. Systolic blood pressure was increased in both NPX rats and NPX rats fed with spironolactone for 5 weeks. Echocardiography revealed concentric left ventricular hypertrophy in uremia, which was attenuated by spironolactone. Enlarged cardiomyocyte size was observed in both left and right ventricles of NPX rats, an effect that was prevented by spironolactone. Mineralocorticoid receptor antagonism attenuated the increase of ventricular brain natriuretic peptide mRNA levels induced by nephrectomy. Left ventricular gene expressions of aldosterone synthase, mineralocorticoid receptor, and hydroxysteroid dehydrogenase type 2 were the same in the 3 groups, whereas gene expression of the glucocorticoid receptor was significantly diminished in chronic renal failure rats. No significant differences in cardiac aldosterone were observed between control rats and NPX rats, although NPX rats fed with spironolactone for 5 weeks showed increased plasma aldosterone levels. However, a significant increase in serum and glucocorticoid-inducible kinase-1 mRNA expression and protein was present in the NPX group; spironolactone treatment significantly reduced serum and glucocorticoid-inducible kinase-1 mRNA and protein in the left ventricle. Uremic rats exhibited a significant increase of superoxide production and reduced nicotinamide-adenine dinucleotide phosphate oxidase subunits expression (NOX-2, NOX-4, and p47) in the left ventricle, which was prevented by the mineralocorticoid receptor antagonist. Our findings provide evidence of the beneficial effects of spironolactone in cardiac hypertrophy and cardiac oxidative stress in chronic renal failure.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>18591458</pmid><doi>10.1161/HYPERTENSIONAHA.107.109645</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2008-08, Vol.52 (2), p.295-300 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_miscellaneous_69355037 |
source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Ovid Autoload |
subjects | Analysis of Variance Animals Biomarkers - analysis Blotting, Western Cardiomegaly - prevention & control Disease Models, Animal Immediate-Early Proteins - genetics Immediate-Early Proteins - metabolism Male Mineralocorticoid Receptor Antagonists - pharmacology Nephrectomy Oxidative Stress - drug effects Probability Protein-Serine-Threonine Kinases - genetics Protein-Serine-Threonine Kinases - metabolism Random Allocation Rats Rats, Sprague-Dawley Receptors, Mineralocorticoid - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - analysis Spironolactone - pharmacology Uremia - physiopathology Urinalysis |
title | Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Prevents Oxidative Stress in Uremic Rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T06%3A28%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mineralocorticoid%20Receptor%20Antagonism%20Attenuates%20Cardiac%20Hypertrophy%20and%20Prevents%20Oxidative%20Stress%20in%20Uremic%20Rats&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Michea,%20Luis&rft.date=2008-08&rft.volume=52&rft.issue=2&rft.spage=295&rft.epage=300&rft.pages=295-300&rft.issn=0194-911X&rft.eissn=1524-4563&rft_id=info:doi/10.1161/HYPERTENSIONAHA.107.109645&rft_dat=%3Cproquest_cross%3E69355037%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69355037&rft_id=info:pmid/18591458&rfr_iscdi=true |